Hsinchu, Taiwan

Hsin-Ping Lin

This inventor holds 1 USPTO granted patent. Top assignee: National Yang Ming Chiao Tung University. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hsin-Ping Lin. Retrieved from https://idiyas.com/inventor/hsin-ping-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hsin-Ping Lin: Innovator in Protein Kinase Inhibition

Introduction

Hsin-Ping Lin is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of selective inhibitors for protein kinases. His work is essential for advancing therapeutic options in various medical conditions.

Latest Patents

Hsin-Ping Lin holds a patent for "Selective inhibitors for protein kinases and pharmaceutical composition and use thereof." This invention provides a compound of formula (I) or the salt thereof, which has potential applications in treating diseases related to protein kinase activity. He has 1 patent to his name, showcasing his innovative approach to drug development.

Career Highlights

Lin is affiliated with National Yang Ming Chiao Tung University, where he engages in research and development activities. His academic background and research focus have positioned him as a key figure in the field of pharmacology and biotechnology.

Collaborations

He has collaborated with notable colleagues, including Jinn-Moon Yang and Tzu-Ying Sung, to further enhance the impact of his research. These collaborations have contributed to the advancement of knowledge in the field of protein kinase inhibitors.

Conclusion

Hsin-Ping Lin's work in developing selective inhibitors for protein kinases represents a significant advancement in pharmaceutical innovation. His contributions are vital for future therapeutic developments in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…